Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cholic Acid for Inborn Errors of Bile Acid Metabolism
NCT00007020Phase 3Completed
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Start
- Jan 1992
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of cholic acid in Inborn Errors Of Bile Acid Metabolism (IEBAM) and peroxisomal disorders, sponsored by Mirum Pharmaceuticals, Inc. Primary endpoint: Number of Participants With Excretion of Atypical Bile Acids in Urine by Category. Started Jan 1992; status: completed.
02
Drugs
cholic acid
03
Conditions
Inborn Errors Of Bile Acid Metabolism (IEBAM)peroxisomal disorders
Beyond the preview
Go deeper on NCT00007020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00007020.